Astec Lifesciences Limited (ASTEC) Stock Statistics & Valuation Metrics

Astec Lifesciences Limited has a market cap or net worth of ₹19.49B. The enterprise value is ₹23.62B.

Astec Lifesciences Limited has 22,413,383 shares outstanding. The number of shares has decreased by -2.65% in one year.

Astec Lifesciences Limited’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is 3.07%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Astec Lifesciences Limited had revenue of 3.81B and earned -1.35B in profits. Earnings per share was -68.71.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Astec Lifesciences Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 0.16%

Astec Lifesciences Limited upcoming earnings date is Oct 24, 2025, TBA (Confirmed).

Astec Lifesciences Limited as a current ratio of 0.93, with Debt / Equity ratio of 236.23%

In the past 12 months, Astec Lifesciences Limited has paid 62.77M in taxes.

Astec Lifesciences Limited EV to EBITDA ratio is -29.96, with an EV/FCF ratio of -65.64.

Astec Lifesciences Limited has ₹27.05M in cash and marketable securities with ₹5.55B in debt, giving a net cash position of ₹5.52B billion.

Gross margin is 8.52%, with operating margin of 6.10%, and net profit margin of -35.34%.

The average price target for Astec Lifesciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―